• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同类型动脉粥样硬化性肾血管疾病的临床表现、特征及预后

Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease.

作者信息

Connolly J O, Higgins R M, Walters H L, Mackie A D, Drury P L, Hendry B M, Scoble J E

机构信息

Renal Unit, King's College Hospital Dulwich, London, UK.

出版信息

QJM. 1994 Jul;87(7):413-21.

PMID:7922293
Abstract

Atherosclerotic renovascular disease (ARD) is an increasingly important cause of renal failure. However, important features of the clinical presentation are not fully described, and the outcome after intervention by angioplasty remains controversial. Ninety-four patients with ARD diagnosed at angiography were reviewed. Twenty-four patients were diabetic. Thirty-nine patients had unilateral renal artery stenosis or occlusion (group A), 28 had bilateral stenosis (group B), and 27 had unilateral occlusion plus contralateral occlusion or stenosis (group C). Two years after presentation, actuarial patient survival was 96%, 74.3% and 47.1% in groups A, B and C, respectively (p < 0.001 for all differences); actuarial renal survival in surviving patients was 97.3%, 82.4% and 44.7%, respectively (p < 0.001 for all differences). Percutaneous transluminal balloon angioplasty (PCTA) was performed in 74 patients. Renal function improved in only a minority of cases, but was stable in 73% of nondiabetic patients 12 months after PCTA. Angioplasty was less effective in diabetic subjects, with only 53.3% having stable renal function at 12 months follow-up. Renal and patient survival were strongly related to the initial angiographic findings. In non-diabetic subjects, PCTA resulted in stabilization of renal function for at least one year in nearly three-quarters of cases, which suggests a benefit from intervention in this disease whose natural history is otherwise of progression.

摘要

动脉粥样硬化性肾血管疾病(ARD)是肾衰竭日益重要的病因。然而,临床表现的重要特征尚未得到充分描述,血管成形术干预后的结局仍存在争议。对94例经血管造影诊断为ARD的患者进行了回顾性研究。24例患者患有糖尿病。39例患者有单侧肾动脉狭窄或闭塞(A组),28例有双侧狭窄(B组),27例有单侧闭塞加对侧闭塞或狭窄(C组)。发病两年后,A组、B组和C组患者的精算生存率分别为96%、74.3%和47.1%(所有差异p<0.001);存活患者的精算肾脏生存率分别为97.3%、82.4%和44.7%(所有差异p<0.001)。74例患者接受了经皮腔内球囊血管成形术(PCTA)。只有少数病例肾功能得到改善,但73%的非糖尿病患者在PCTA术后12个月肾功能稳定。血管成形术对糖尿病患者效果较差,在12个月随访时只有53.3%的患者肾功能稳定。肾脏和患者的生存率与最初的血管造影结果密切相关。在非糖尿病患者中,PCTA在近四分之三的病例中使肾功能稳定至少一年,这表明对这种自然病程为进展性的疾病进行干预是有益的。

相似文献

1
Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease.不同类型动脉粥样硬化性肾血管疾病的临床表现、特征及预后
QJM. 1994 Jul;87(7):413-21.
2
Primary renal artery stenting: characteristics and outcomes after 363 procedures.原发性肾动脉支架置入术:363例手术的特征与结果
Am Heart J. 2001 Aug;142(2):314-23. doi: 10.1067/mhj.2001.116958.
3
[The long-term results on arterial pressure and kidney function after the percutaneous transluminal dilatation of renal artery stenosis].经皮腔内肾动脉狭窄扩张术后动脉血压及肾功能的长期结果
Med Clin (Barc). 1997 Mar 15;108(10):366-72.
4
Long-term survival after surgical revascularization for atherosclerotic renal artery disease.
J Urol. 1997 Jul;158(1):38-41. doi: 10.1097/00005392-199707000-00011.
5
Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention?哪些患有高血压和动脉粥样硬化性肾动脉狭窄的患者能从即刻干预中获益?
J Hum Hypertens. 2004 Feb;18(2):91-6. doi: 10.1038/sj.jhh.1001641.
6
Salvage of the solitary kidney by insertion of a renal artery stent.通过插入肾动脉支架挽救孤立肾。
AJR Am J Roentgenol. 1998 Jul;171(1):217-22. doi: 10.2214/ajr.171.1.9648792.
7
Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease.
Br J Surg. 2002 Jun;89(6):737-40. doi: 10.1046/j.1365-2168.2002.02144.x.
8
Options for therapy of ischemic nephropathy: role of angioplasty and surgery.缺血性肾病的治疗选择:血管成形术和手术的作用。
Semin Nephrol. 1996 Jan;16(1):53-60.
9
Implications of acute functional injury following percutaneous renal artery intervention.经皮肾动脉介入术后急性功能损伤的影响
Ann Vasc Surg. 2008 Nov;22(6):783-9. doi: 10.1016/j.avsg.2008.06.006. Epub 2008 Aug 9.
10
Renal angioplasty and stenting under protection: the way for the future?保护性肾血管成形术和支架置入术:未来之路?
Catheter Cardiovasc Interv. 2003 Nov;60(3):299-312. doi: 10.1002/ccd.10669.

引用本文的文献

1
Ten-Year Outcomes in Patients Undergoing Simultaneous Coronary and Renal Angiography-Does Renal Artery Stenosis Matter?接受冠状动脉和肾动脉同步血管造影术患者的十年预后——肾动脉狭窄有影响吗?
J Clin Med. 2024 Jun 7;13(12):3374. doi: 10.3390/jcm13123374.
2
The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study.蛋白尿和既往心血管疾病在动脉粥样硬化性肾血管疾病所有主要临床结局中的重要性——一项单中心观察性研究
BMC Nephrol. 2016 Dec 7;17(1):198. doi: 10.1186/s12882-016-0409-1.
3
Renovascular hypertension: screening and modern management.
肾血管性高血压:筛查与现代管理。
Eur Heart J. 2011 Jul;32(13):1590-8. doi: 10.1093/eurheartj/ehq510. Epub 2011 Jan 27.
4
Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.动脉粥样硬化性肾血管疾病中的肾衰竭:发病机制、诊断及干预
Postgrad Med J. 2001 Feb;77(904):68-74. doi: 10.1136/pmj.77.904.68.
5
Atherosclerotic renal artery stenosis: surgery, percutaneous transluminal angioplasty, or medical therapy?
Curr Hypertens Rep. 2000 Oct;2(5):482-9. doi: 10.1007/s11906-000-0032-0.
6
Atherosclerotic stenosis of the renal arteries. Indications for intervention.肾动脉粥样硬化性狭窄。干预指征。
Tex Heart Inst J. 1998;25(1):34-9.
7
Arterial stents in the management of neurofibromatosis and renovascular hypertension in a pediatric patient: case report of a new treatment modality.动脉支架在一名儿科患者神经纤维瘤病和肾血管性高血压治疗中的应用:一种新治疗方式的病例报告
Cardiovasc Intervent Radiol. 1995 Nov-Dec;18(6):414-8. doi: 10.1007/BF00338313.